These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9133402)

  • 1. Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with D1/D5, but not D2, dopamine receptor antagonists.
    Emmi A; Rajabi H; Stewart J
    J Neurosci; 1997 May; 17(10):3840-6. PubMed ID: 9133402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with glutamate receptor antagonists MK-801 and CPP.
    Emmi A; Rajabi H; Stewart J
    J Neurosci; 1996 Aug; 16(16):5216-24. PubMed ID: 8756450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine.
    Moroz IA; Peciña S; Schallert T; Stewart J
    Exp Neurol; 2004 Sep; 189(1):78-93. PubMed ID: 15296838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1105-11. PubMed ID: 8263772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of selective dopamine D1- and D2-type receptor antagonists on the development of behavioral sensitization to 7-OH-DPAT.
    Mattingly BA; Himmler C; Bonta T; Rice LL
    Psychopharmacology (Berl); 1998 Dec; 140(4):387-97. PubMed ID: 9888612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats.
    Konieczny J; Lenda T; Czarnecka A
    Neuroscience; 2016 Jun; 324():92-106. PubMed ID: 26964686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
    LaHoste GJ; Marshall JF
    Behav Brain Res; 1990 May; 38(3):233-42. PubMed ID: 1973041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of dopamine levels in intrastriatal grafts of fetal mesencephalic cell suspension: an in vivo voltammetric approach.
    Moukhles H; Forni C; Nieoullon A; Daszuta A
    Exp Brain Res; 1994; 102(1):10-20. PubMed ID: 7895786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions.
    Altar CA; Boylan CB; Fritsche M; Jones BE; Jackson C; Wiegand SJ; Lindsay RM; Hyman C
    J Neurochem; 1994 Sep; 63(3):1021-32. PubMed ID: 7519657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of dopamine D1 and D2 receptors on striatal acetylcholine release in rats.
    Ikarashi Y; Takahashi A; Ishimaru H; Arai T; Maruyama Y
    Brain Res Bull; 1997; 43(1):107-15. PubMed ID: 9205804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of D1- or D2-receptors in drug-naive rats with different degrees of unilateral nigro-striatal dopamine lesions.
    Fornaguera J; Huston JP; Carey RJ; Schwarting RK
    Psychopharmacology (Berl); 1995 May; 119(2):145-54. PubMed ID: 7659761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists.
    O'Dell SJ; Weihmuller FB; Marshall JF
    J Neurochem; 1993 May; 60(5):1792-9. PubMed ID: 8473897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats.
    Robinson TE; Whishaw IQ
    Brain Res; 1988 May; 450(1-2):209-24. PubMed ID: 3135914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic effects of single intrastriatal injections of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium studied by microdialysis in freely moving rats.
    Espino A; Cutillas B; Tortosa A; Ferrer I; Bartrons R; Ambrosio S
    Brain Res; 1995 Oct; 695(2):151-7. PubMed ID: 8556325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic regulation of serotonin release in the substantia nigra of the freely moving rat using microdialysis.
    Thorré K; Sarre S; Smolders I; Ebinger G; Michotte Y
    Brain Res; 1998 Jun; 796(1-2):107-16. PubMed ID: 9689460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system.
    Robinson TE; Mocsary Z; Camp DM; Whishaw IQ
    J Neurosci; 1994 May; 14(5 Pt 1):2687-96. PubMed ID: 7514209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ; Marshall JF
    Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.